Skip to main content

More weakness still to come for many EMs

The roll-out of COVID-19 vaccines is getting underway across EMs, but in many cases progress has been slow-going. In the meantime, many countries are suffering from worsening outbreaks. New cases are high and/or rising across Latin America, particularly in Brazil where a more virulent variant is circulating and pressuring its healthcare system. It’s a similar story in South Africa. While new cases have fallen in much of Emerging Europe, they remain high in per capita terms. In these places, restrictions will need to remain tight in Q1 and in some cases beyond, which will continue to weigh on activity.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.